Marshall Wace LLP Purchases New Shares in Crescent Capital BDC, Inc. (NASDAQ:CCAP)

Marshall Wace LLP purchased a new position in shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 40,854 shares of the company’s stock, valued at approximately $767,000. Marshall Wace LLP owned about 0.11% of Crescent Capital BDC as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also added to or reduced their stakes in CCAP. Tucker Asset Management LLC bought a new stake in shares of Crescent Capital BDC during the 4th quarter worth $167,000. XTX Topco Ltd purchased a new position in Crescent Capital BDC in the second quarter valued at about $195,000. Alpine Global Management LLC bought a new position in shares of Crescent Capital BDC during the 1st quarter valued at approximately $217,000. Catalina Capital Group LLC bought a new position in shares of Crescent Capital BDC during the 2nd quarter valued at approximately $220,000. Finally, Hennion & Walsh Asset Management Inc. purchased a new stake in shares of Crescent Capital BDC during the 1st quarter worth approximately $303,000. 49.46% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several brokerages have weighed in on CCAP. LADENBURG THALM/SH SH started coverage on Crescent Capital BDC in a report on Monday, September 30th. They set a “buy” rating and a $20.00 price objective for the company. Wells Fargo & Company dropped their price target on Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating on the stock in a research report on Wednesday, August 14th. Finally, Bank of America decreased their price objective on Crescent Capital BDC from $20.00 to $19.00 and set a “buy” rating for the company in a report on Thursday, August 15th. One analyst has rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $19.00.

Crescent Capital BDC Stock Up 0.5 %

CCAP stock opened at $18.27 on Wednesday. The stock has a 50-day simple moving average of $18.32 and a two-hundred day simple moving average of $18.19. Crescent Capital BDC, Inc. has a twelve month low of $15.03 and a twelve month high of $19.63. The firm has a market capitalization of $677.12 million, a PE ratio of 6.49 and a beta of 0.81. The company has a quick ratio of 1.40, a current ratio of 1.40 and a debt-to-equity ratio of 1.17.

Crescent Capital BDC (NASDAQ:CCAP) last posted its earnings results on Monday, August 12th. The company reported $0.59 earnings per share for the quarter, topping analysts’ consensus estimates of $0.58 by $0.01. The business had revenue of $48.95 million for the quarter, compared to analyst estimates of $48.05 million. Crescent Capital BDC had a net margin of 51.61% and a return on equity of 12.03%. During the same quarter in the prior year, the firm posted $0.56 EPS. On average, equities analysts predict that Crescent Capital BDC, Inc. will post 2.34 EPS for the current fiscal year.

Crescent Capital BDC Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, October 15th. Shareholders of record on Monday, September 30th will be paid a $0.42 dividend. This is a positive change from Crescent Capital BDC’s previous quarterly dividend of $0.09. This represents a $1.68 dividend on an annualized basis and a yield of 9.20%. The ex-dividend date is Monday, September 30th. Crescent Capital BDC’s dividend payout ratio is currently 59.79%.

About Crescent Capital BDC

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.